ITP: Biologic Beat Placebo, but Few Patients Improved ...Middle East

Patients with chronic immune thrombocytopenia (ITP) fared better on intravenous efgartigimod (Vyvgart) than a placebo, but only 21.8% reached the primary endpoint of sustained platelet. MDedge News

Hence then, the article about itp biologic beat placebo but few patients improved was published today ( Thursday 15/12/2022 - 06:25 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ITP: Biologic Beat Placebo, but Few Patients Improved )

Also on site :

• This Guitarist Helped Shape One of the Most Iconic Sounds of the '90s
• 32 Years Ago Today, Iconic '90s Rocker Died at the Age of 27
• Charli xcx Management Clarifies Sky Ferreira Claims About ‘Wuthering Heights’ Credits